^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Marginal Zone Lymphoma |
| Regimen: | G-CHOP (cyclophosphamide + doxorubicin hydrochloride + Gazyva (obinutuzumab) + + vincristine) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Marginal Zone Lymphoma: Second-Line and subsequent therapy…Other recommended regimen…CHOP + obinutuzumab (category 2B)
